The aims of this educational meeting, held in Vienna, Austria, were to explore the significant advances that have occurred in multiple sclerosis (MS) management over the past two decades, to highlight modern-day perspectives and challenges and to consider the impact of the new oral first-line treatments expected to enter the MS market shortly. The meeting was attended by 372 delegates with neurological interests from 30 countries and was opened by Per Soelberg Sørensen (Copenhagen, Denmark).
Bachir Taouli, Ahmed Ba‐Ssalamah, Julius Chapiro, Jagpreet Chhatwal, Kathryn J. Fowler, Tae Wook Kang, Gesine Knobloch, Dow‐Mu Koh, Masatoshi Kudo, Jeong Min Lee, Takamichi Murakami, David J. Pinato, Kristina I. Ringe, Bin Song, Parissa Tabrizian, Jin Wang, Jeong Hee Yoon, Mengsu Zeng, Jian Zhou, Valérie Vilgrain
Angelo Ghezzi, Brenda Banwell, Alexey Boyко, Maria Pia Amato, Banu Anlar, Morten Blinkenberg, Maartje Boon, Massimo Filippi, Sergiusz Jóźwiak, I. A. Ketelslegers, Barbara Kornek, Ming Lim, Eva Lindström, Čongor Nadj, Rinze F. Neuteboom, Maria A. Rocca, Kevin Rostásy, Marc Tardieu, Evangeline Wassmer, Coriene E. Catsman‐Berrevoets, Rogier Hintzen
Discussion(0)
No comments yet. Be the first to comment.